LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 58.15 | 27.76 | 638 | 5906 | 0.1080 | 0.4999 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 58.15 | 27.76 | 12 | 5906 | 0.0020 | -0.1028 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 58.15 | 27.76 | 780 | 5906 | 0.1321 | 0.5393 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 59.85 | 27.76 | 67 | 6062 | 0.0111 | 0.1201 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 59.85 | 27.76 | 639 | 6062 | 0.1054 | 0.4972 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 59.85 | 27.76 | 6 | 6062 | 0.0010 | -0.1789 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 59.85 | 27.76 | 737 | 6062 | 0.1216 | 0.5250 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 61.56 | 27.76 | 58 | 6217 | 0.0093 | 0.0990 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 61.56 | 27.76 | 633 | 6217 | 0.1018 | 0.4926 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 61.56 | 27.76 | 5 | 6217 | 0.0008 | -0.1971 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 61.56 | 27.76 | 693 | 6217 | 0.1115 | 0.5100 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 63.26 | 27.76 | 46 | 6465 | 0.0071 | 0.0663 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 63.26 | 27.76 | 628 | 6465 | 0.0971 | 0.4868 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 63.26 | 27.76 | 6 | 6465 | 0.0009 | -0.1770 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 63.26 | 27.76 | 681 | 6465 | 0.1053 | 0.5022 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 64.97 | 27.76 | 44 | 6656 | 0.0066 | 0.0600 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 64.97 | 27.76 | 635 | 6656 | 0.0954 | 0.4858 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 64.97 | 27.76 | 4 | 6656 | 0.0006 | -0.2173 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 64.97 | 27.76 | 685 | 6656 | 0.1029 | 0.5001 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 66.67 | 27.76 | 39 | 6695 | 0.0058 | 0.0439 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 66.67 | 27.76 | 626 | 6695 | 0.0935 | 0.4825 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 66.67 | 27.76 | 6 | 6695 | 0.0009 | -0.1760 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 66.67 | 27.76 | 679 | 6695 | 0.1014 | 0.4978 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 68.37 | 27.76 | 45 | 6879 | 0.0065 | 0.0626 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 68.37 | 27.76 | 621 | 6879 | 0.0903 | 0.4781 | MN20160318_Q01 | E13 |